Grosse-Wilde H - Search Results

1

Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992.

Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizu RM, Grosse-Wilde H. Pouletty P, et al. Tissue Antigens. 1993 Jul;42(1):45-54. doi: 10.1111/j.1399-0039.1993.tb02166.x. Tissue Antigens. 1993. PMID: 7504328

2

Soluble HLA class I and class II antigens in patients with multiple sclerosis.

Ott M, Seidl C, Westhoff U, Stecker K, Seifried E, Fischer PA, Grosse-Wilde H. Ott M, et al. Tissue Antigens. 1998 Mar;51(3):301-4. doi: 10.1111/j.1399-0039.1998.tb03106.x. Tissue Antigens. 1998. PMID: 9550332

3

Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations.

Grosse-Wilde H, Blasczyk R, Westhoff U. Grosse-Wilde H, et al. Tissue Antigens. 1992 Feb;39(2):74-7. doi: 10.1111/j.1399-0039.1992.tb01910.x. Tissue Antigens. 1992. PMID: 1574801

4

Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay.

Doxiadis I, Westhoff U, Grosse-Wilde H. Doxiadis I, et al. Blut. 1989 Nov;59(5):449-54. doi: 10.1007/BF00349066. Blut. 1989. PMID: 2684299

5

Soluble HLA class I and class II concentrations in factor VIII and PCC preparations.

Westhoff U, Grosse-Wilde H. Westhoff U, et al. Vox Sang. 1995;68(2):73-6. doi: 10.1111/j.1423-0410.1995.tb02556.x. Vox Sang. 1995. PMID: 7762224

6

Detection of soluble HLA-G molecules in plasma and amniotic fluid.

Rebmann V, Pfeiffer K, Pässler M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H. Rebmann V, et al. Tissue Antigens. 1999 Jan;53(1):14-22. doi: 10.1034/j.1399-0039.1999.530102.x. Tissue Antigens. 1999. PMID: 10082427

7

Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2.

Wang X, Liang B, Rebmann V, Lu J, Celis E, Kageshita T, Grosse-Wilde H, Ferrone S. Wang X, et al. Tissue Antigens. 2003 Aug;62(2):139-48. doi: 10.1034/j.1399-0039.2003.00087.x. Tissue Antigens. 2003. PMID: 12889994

8

Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay.

Westhoff U, Thinnes FP, Götz H, Grosse-Wilde H. Westhoff U, et al. Vox Sang. 1991;61(2):106-10. doi: 10.1111/j.1423-0410.1991.tb00255.x. Vox Sang. 1991. PMID: 1763495

9

14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.

Ozawa M, Terasaki PI, Lee JH, Castro R, Alberu J, Alonso C, Alvarez I, Toledo R, Alvez H, Monterio M, Teixeira J, Campbell P, Ciszek M, Charron D, Gautreau C, Christiansen F, Conca R, Gomez B, Monteon F, Grosse-Wilde H, Heinemann F, Humar I, Kamoun M, Kimball P, Kobayashi T, Kupatawintu P, Leech S, LeFor W, Mehra N, Panigrahi A, Naumova E, Norman D, Piazza A, Poli F, Colombo B, Roy R, Schonemann C, Sireci G, Tanabe K, Ishida H, Van den Berg-Loonen E, Zeevi A. Ozawa M, et al. Tissue Antigens. 2007 Apr;69 Suppl 1:174-9. doi: 10.1111/j.1399-0039.2006.00765.x. Tissue Antigens. 2007. PMID: 17445195

10

Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations.

Blasczyk R, Westhoff U, Grosse-Wilde H. Blasczyk R, et al. Lancet. 1993 Mar 27;341(8848):789-90. doi: 10.1016/0140-6736(93)90563-v. Lancet. 1993. PMID: 8096001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters